The global parenterally administered medical nutrition market is estimated to represent incremental opportunity of US$ 2,577.4 Mn between 2017 and 2025. The market is expected to grow from US$ 3,468.9 Mn in 2017 to US$ 6,046.3 Mn by 2025 end. This represents a CAGR of 7.2% over the forecast period.
The Advanced Medical Nutrition Market To Revitalize Post Covid-19 (2025
“Medical Nutrition Market: Global Industry Analysis (2012-2016) and Forecast 2017–2025,” a
new report by Persistence Market Research concentrates on the parenteral nutrition segment
and its overall performance in the global medical nutrition market for the duration of eight
years. The report segments the global parenterally administered medical nutrition market on
the basis of product type, distribution channel, nutrition type and region.
Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/16588
Baxter International Inc.
Braun Melsungen AG.
Fresenius Kabi AG
Mead Johnson & Company, LLC
Sichuan Kelun Pharmaceutical Company Limited
Otsuka Pharmaceuticals Co., Ltd.
Demo S.A. Pharmaceutical Industry
Global Medical Nutrition Market: Forecast by Product Type
This segment is divided into Amino Acid Solution, Multiple Vitamins and Antioxidants, Lipid
Emulsion, Trace Elements, 2C Bags, and 3C Bags. The Amino Acid Solution segment dominated
the global parenteral medical nutrition market in terms of revenue in 2016, and the trend is
projected to grow throughout the forecast period. Amino Acid Solution segment is the most
attractive segment, with a market attractiveness index of 1.8 over the forecast period.
Get To Know Methodology of Report
Global Medical Nutrition Market: Forecast by Distribution Channel
Hospital Pharmacies, Retail Pharmacies, Compound Pharmacies are the sub-segments in this
category. The Retail Pharmacies segment is expected to be the second most lucrative market in
the global parenteral nutrition market by distribution channel, with an attractiveness index of
0.5 during the forecast period.
The Retail Pharmacies segment is estimated to account for 13.1% value share in 2017. Hospital
Pharmacies will ho